ConductScience.org, home

Paper24039628

Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy.

Scarlett UK and 1 other. Expert Rev Obstet Gynecol, 2012. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy. Papers, record 24039628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24039628

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy.
PubMed
Journal
Expert Rev Obstet Gynecol
PubMed
Year
2012
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.35
iCite
Revised in PubMed
2021-10-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Scarlett UKUciane K
2Conejo-Garcia JRJose R

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
F31 CA134188NCI NIH HHSUnited StatesF31CA134188PubMed and NIHNIH RePORTER
R01 CA124515NCI NIH HHSUnited StatesR01CA124515PubMed and NIHNIH RePORTER
R01 CA157664NCI NIH HHSUnited StatesR01CA157664PubMed and NIHNIH RePORTER
U54 CA151662NCI NIH HHSUnited StatesU54CA151662PubMed and NIHNIH RePORTER

Download CSV of grants

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122307839Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer.Cancer Res2012https://conductscience.org/library/papers/22307839PubMed
28420671Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality.Cancer1993https://conductscience.org/library/papers/8420671PubMed
322418702Mesothelin, a novel immunotherapy target for triple negative breast cancer.Breast Cancer Res Treat2012https://conductscience.org/library/papers/22418702PubMed
421941296The parallel lives of angiogenesis and immunosuppression: cancer and other tales.Nat Rev Immunol2011https://conductscience.org/library/papers/21941296PubMed
518157142Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.Nat Med2008https://conductscience.org/library/papers/18157142PubMed
617360651Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17360651PubMed
79377574Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.Cancer Res1997https://conductscience.org/library/papers/9377574PubMed
815007094Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN.J Exp Med2004https://conductscience.org/library/papers/15007094PubMed
921436454CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.Science2011https://conductscience.org/library/papers/21436454PubMed
1022065722A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.Cancer Res2012https://conductscience.org/library/papers/22065722PubMed
1119738057In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells.Cancer Res2009https://conductscience.org/library/papers/19738057PubMed
1212529460Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.N Engl J Med2003https://conductscience.org/library/papers/12529460PubMed
1316120050Immunotherapy for gynaecological malignancies.Expert Opin Biol Ther2005https://conductscience.org/library/papers/16120050PubMed
1420605485Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.Immunity2010https://conductscience.org/library/papers/20605485PubMed
1522351743Mesothelin-targeted agents in clinical trials and in preclinical development.Mol Cancer Ther2012https://conductscience.org/library/papers/22351743PubMed
1621113407CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells.Oncotarget2010https://conductscience.org/library/papers/21113407PubMed
1719474385Cancer statistics, 2009.CA Cancer J Clin2009https://conductscience.org/library/papers/19474385PubMed
1820400704CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells.J Immunol2010https://conductscience.org/library/papers/20400704PubMed
1921957230Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.J Natl Cancer Inst2011https://conductscience.org/library/papers/21957230PubMed
2015334073Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A.Nat Med2004https://conductscience.org/library/papers/15334073PubMed

See all 51 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
37760595Specific Tumor Localization of Immunogenic Lipid-Coated Mesoporous Silica Nanoparticles following Intraperitoneal Administration in a Mouse Model of Serous Epithelial Ovarian Cancer.Cancers (Basel)2023https://conductscience.org/library/papers/37760595PubMed
36741442Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis.PNAS Nexus2022https://conductscience.org/library/papers/36741442PubMed
35155439Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer.Front Cell Dev Biol2022https://conductscience.org/library/papers/35155439PubMed
33800608Chimeric Antigen Receptor Design and Efficacy in Ovarian Cancer Treatment.Int J Mol Sci2021https://conductscience.org/library/papers/33800608PubMed
32850861Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy.Front Cell Dev Biol2020https://conductscience.org/library/papers/32850861PubMed
32059873Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition.Nanomedicine2020https://conductscience.org/library/papers/32059873PubMed
29338446The latest animal models of ovarian cancer for novel drug discovery.Expert Opin Drug Discov2018https://conductscience.org/library/papers/29338446PubMed
27622059Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103(+) dendritic cells in late-stage ovarian cancer.Oncoimmunology2016https://conductscience.org/library/papers/27622059PubMed
27076627VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells.Clin Cancer Res2016https://conductscience.org/library/papers/27076627PubMed
26150590M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis.J Natl Cancer Inst2015https://conductscience.org/library/papers/26150590PubMed
25502429New ways to successfully target tumor vasculature in ovarian cancer.Curr Opin Obstet Gynecol2015https://conductscience.org/library/papers/25502429PubMed

Download CSV of cited by

Genes29

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCL206364PubTator's text mininghttps://conductscience.org/library/genes/6364NCBI Gene
CCL36348PubTator's text mininghttps://conductscience.org/library/genes/6348NCBI Gene
CCL76354PubTator's text mininghttps://conductscience.org/library/genes/6354NCBI Gene
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
CD86942PubTator's text mininghttps://conductscience.org/library/genes/942NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CXCL103627PubTator's text mininghttps://conductscience.org/library/genes/3627NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
CXCR47852PubTator's text mininghttps://conductscience.org/library/genes/7852NCBI Gene
DICER123405PubTator's text mininghttps://conductscience.org/library/genes/23405NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
FAP2191PubTator's text mininghttps://conductscience.org/library/genes/2191NCBI Gene
IDO13620PubTator's text mininghttps://conductscience.org/library/genes/3620NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
ITGAM3684PubTator's text mininghttps://conductscience.org/library/genes/3684NCBI Gene
ITGAX3687PubTator's text mininghttps://conductscience.org/library/genes/3687NCBI Gene
LY754065PubTator's text mininghttps://conductscience.org/library/genes/4065NCBI Gene

See all 29 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24039628

GET https://conductscience.org/api/papers/v1/24039628/references?page=2